Cardinal Health (CAH) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Since a changing earnin ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.Zacks Premium includes access to the Zacks Style Scores a ...

Cardinal Health (CAH) ended the recent trading session at $148.96, demonstrating a -3.64% change from the preceding day's closing price. The stock's performance was behind the S&P 500's daily loss of 0.5%. Meanwhile, the Dow experienced a drop of 0.38%, and the technology-dominated Nasdaq saw a decrease of 0.5%. Shares of the prescription drug distributor have appreciated by 3.58% over the course of the past month, outperforming the Medical sector's loss of 0.7%, and the S&P 500's gain of 2.74%.Investors wi ...

Cardinal Health, Inc. (NYSE:CAH) is included among the 11 Cheap Quarterly Dividend Stocks to Buy Right Now. Why Cardinal Health (CAH) Stands Out Among Cheap Quarterly Dividend Stocks Cardinal Health, Inc. (NYSE:CAH) is a major distributor of branded and generic drugs, medical supplies, laboratory products, and supply chain services for healthcare providers. It serves more than 90% of hospitals in the US and has operations in over 30 countries. Cardinal Health, Inc. (NYSE:CAH) is also well-regarded as a ...

PresentationAllen LutzBofA Securities, Research Division All right. Good morning, everyone. Thank you for attending. My name is Allen Lutz, health care tech and distribution analyst here at Bank of America. We are ecstatic to have the Cardinal Health management team here. We have Jason Hollar, CEO; Aaron Alt, CFO; and Head of Investor Relations, Matt Sims. I think, Matt, you had a couple of comments before we get started. ...

Cardinal Health (NYSE:CAH) 2025 Conference September 24, 2025 11:10 AM ET Company ParticipantsAaron Alt - CFOMatt Sims - Head of Investor RelationsJason Hollar - CEOConference Call ParticipantsAllen Lutz - Healthcare Tech and Distribution AnalystAllen LutzWe are ecstatic to have the Cardinal Health Management Team here. We have Jason Hollar, CEO, Aaron Alt, CFO, and Head of Investor Relations, Matt Sims. I think, Matt, you had a couple of comments before we get started.Matt SimsYeah, thanks for hosting us, ...

Accessibility StatementSkip Navigation DUBLIN, Ohio, Sept. 23, 2025 /PRNewswire/ -- Cardinal Health (NYSE:Â CAH) plans to release first-quarter financial results for its fiscal year 2026 on October 30, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern. To access the webcast and corresponding slide presentation, visit Cardinal Health's Investor Relations page. No access code is required. Presentation slides an ...

Key Takeaways CAH unveiled a new Consumer Health Logistics Center in Groveport, OH.CAH's 350,000-sq-ft hub adds 150 jobs and integrates robotics and automation.Facility anchors CAH's multiyear strategy to modernize distribution nationwide.Cardinal Health (CAH) recently unveiled its Consumer Health Logistics Center in Groveport, OH. This is a 350,000-square-foot facility designed to serve as a centralized replenishment hub for over-the-counter medicines, treatments, and diagnostic products. Distributed acros ...

公司概况 - 总部位于俄亥俄州都柏林的Cardinal Health Inc (CAH) 是一家医疗服务和产品公司 市值达354亿美元[1] - 公司为医院、医疗系统、药房、门诊手术中心、临床实验室、医生办公室和家庭患者提供定制化解决方案[1] - 公司专注于复杂高需求治疗领域 通过分析技术平台和增值服务实现差异化 拥有数十年经验和全球业务[2] 市值分类 - 公司符合大盘股定义（市值超100亿美元） 在医疗分销行业具有规模影响力和主导地位[2] 股价表现（短期） - 股价较52周高点168.44美元（7月1日）下跌11.9%[3] - 过去三个月股价下跌8.6% 同期标普500指数上涨9.5%[3] - 8月12日因混合季度业绩股价单日暴跌7.2%[5] 股价表现（长期） - 过去52周股价累计上涨31% 超越标普500指数同期的17.3%涨幅[4] - 年初至今股价上涨25.5% 高于标普500指数12.3%的回报率[4] 技术指标 - 7月下旬以来股价持续低于50日移动平均线[4] - 过去一年股价始终高于200日移动平均线[4] 财务业绩 - 第四季度调整后每股收益2.08美元 同比增长13% 超出市场预期的2.03美元[5] - 第四季度营收602亿美元 略低于分析师预期 仅实现边际同比增长[5] 同业比较 - 过去52周表现落后于竞争对手McKesson Corporation (MCK) 33.4%的涨幅[6] - 年初至今表现优于MCK的21.7%回报率[6]

DUBLIN, Ohio , Sept. 15, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today is showcasing its newly operational Consumer Health Logistics Center, a 350,000-square-foot facility in Groveport, Ohio. ...